Trinity Innovation Bioventure Singapore
Singapore, Singapore · Series A → Series B
Their stated focus (public profile)
Trinity Innovation Bioventure Singapore (TIBS) is a licensed biomed venture capital fund focused on innovation and value investment in the biomedical sector, with a deep emphasis on Asia markets. Founded in 2018 as part of the Trinity Innovation Fund group, it manages multiple VC funds across the region. The fund targets biotech and pharmaceutical companies, particularly in areas such as drug discovery, new drug development, and platform technologies.
Stages: Series A → Series B
Sectors: Life sciences, Healthtech
On file: 5 partners on record · 10 companies on record
Website: trinity-fund.com.sg
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.